Prospective screening increases the detection of potentially curable hepatocellular carcinoma: Results in 8900 high-risk patients

HPB

Volumn 15, Issue 12, 2013, Pages 985-990

  Izzo, Francesco ^a   Piccirillo, Mauro ^a   Albino, Vittorio ^a   Palaia, Raffaele ^a   Belli, Andrea ^a   Granata, Vincenza ^a   Setola, Sergio ^a   Fusco, Roberta ^a   Petrillo, Antonella ^a   Orlando, Raffaele ^b   Tosone, Grazia ^b   Scordino, Fabrizio ^b   Curley, Steven A ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN;

ADULT; AGED; ALPHA FETOPROTEIN BLOOD LEVEL; CANCER SCREENING; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CHRONIC ACTIVE HEPATITIS; CHRONIC HEPATITIS; CONFERENCE PAPER; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SURVIVAL;

ALPHA-FETOPROTEINS; BIOPSY; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; ETHANOL; HEPATECTOMY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INJECTIONS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84887317145     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12080     Document Type: Conference Paper

References (36)

1. El-Serag HB,. (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142: 1264-1273.
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP,. (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45: 529-538.
3. Nathan H, Schulick RD, Choti MA, Pawlik TM,. (2009) Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 249: 799-805.
4. Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, et al. (2011) Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 253: 453-469.
5. Liu JH, Chen PW, Asch SM, Busuttil RW, Ko CY,. (2004) Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol 11: 298-303.
6. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. (2008) Neither multiple tumours nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134: 1908-1916.
7. Fan ST, Mau Lo C, Poon RT, Yeung C, Leung Liu C, Yuen WK, et al. (2011) Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 253: 745-758.
8. Poon RT, Fan ST, Lo CM, Liu CL, Wong J,. (2007) Difference in tumour invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on longterm survival. Ann Surg 245: 51-58.
9. Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M,. (2007) Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 245: 909-922.
10. Barazani Y, Hiatt JR, Tong MJ, Busuttil RW,. (2007) Chronic viral hepatitis and hepatocellular carcinoma. World J Surg 31: 1245-1250.
11. Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, et al. (2002) Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high-risk group in Taiwan. Int J Cancer 98: 257-261.
12. Mok TS, Yeo W, Yu S, Lai P, Chan HL, Chan AT, et al. (2005) An intensive surveillance programme detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results. J Clin Oncol 23: 8041-8047.
13. Ren FY, Piao XX, Jin AL,. (2006) Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma. World J Gastroenterol 12: 4656-4659.
14. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, et al. (2004) Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126: 1005-1014.
15. Yuen MF, Lai CL,. (2003) Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness. Ann Oncol 14: 1463-1467.
16. Cucchetti A, Trevisani F, Cescon M, Ercolani G, Farinati F, Poggio PD, et al. (2012) Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. J Hepatol 56: 1089-1096.
17. Gannon CJ, Izzo F, Aloia TA, Pignata S, Nasti G, Vallone P, et al. (2009) Can hepatocellular cancer screening increase the proportion of longterm survivors? Hepatogastroenterology 56: 1152-1156.
18. Sarasin FP, Giostra E, Hadengue A,. (1996) Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh class A cirrhosis. Am J Med 101: 422-434.
19. Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, et al. (2009) Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 136: 138-148.
20. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. (2006) REVEAL-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73.
21. Chen JG, Parkin DM, Chen QG, Lu JH, Shen QJ, Zhang BC, et al. (2003) Screening for liver cancer: results of a randomized controlled trial in Qidong, China. J Med Screen 10: 204-209.
22. Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, et al. (2009) Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 30: 37-47.
23. Zhang B, Yang B,. (1999) Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer. J Med Screen 6: 108-110.
24. Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, et al. (2008) EpCAM and alphafetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68: 1451-1461.
25. Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, et al. (2005) HALT-C Trial Group. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C trial. J Hepatol 43: 434-441.
26. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012 Mar; 48: 599-641.
27. Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, et al. (2001) Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 91: 561-569.
28. Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, et al. (2007) Clinical utility of AFPL3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol 102: 2196-2205.
29. Altekruse SF, McGlynn KA, Reichman ME,. (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27: 1485-1491.
30. Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE,. (2012) Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology 55: 476-482.
31. Llovet JM, Bustamanta J, Castells A, Vilana R, Ayuso Mdel C, Sala M, et al. (1999) Natural history of untreated non-surgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29: 62-67.
32. Cancer of the Liver Program (CLIP) Investigators. (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28: 751-755.
33. Changchien CS, Chen CL, Yen YH, Wang JH, Hu TH, Lee CM, et al. (2008) Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J Gastroenterol 43: 159-170.
34. Sarpel U, Schwartz M,. (2007) Liver transplantation for hepatocellular carcinoma. Hepatol Res 37 (Suppl.): 264-266.
35. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Sschiavo M, Mariani L, et al. (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10: 35-43.
36. Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, et al. (2009) Liver resection for transplantable hepatocellular carcinoma: longterm survival and role of secondary liver transplantation. Ann Surg 250: 738-746.